当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3493111
自主品牌
已选条件
-
T81046Tamtuvetmab；化合物 TamtuvetmabAT-005|||AT005；AT-005|||AT005
Tamtuvetmab (AT-005), a caninised version of blontuvetmab targeting CD52, enhances progression-free survival (PFS) and demonstrates in vivo efficacy for treating na?ve T-cell lymphoma (LSA) in dogs. The compound has received veterinary approval [1] [2].
价 格：￥电议型 号：T81046产 地：中国大陆
-
T81042Taplitumomab paptox；化合物 Taplitumomab paptoxTaplitumomab paptox
Taplitumomab paptox is an anti-CD19 monoclonal antibody utilized in cancer research.
价 格：￥电议型 号：T81042产 地：中国大陆
-
T81024Tefibazumab；化合物 TefibazumabINH-H 2002；INH-H 2002
Tefibazumab, a humanized IgG1κ monoclonal antibody, targets and binds to clumping factor A, an adhesion protein expressed on the surface of Staphylococcus aureus, and is under investigation for the treatment of serious Staphylococcus aureus infections [1] [2].
价 格：￥电议型 号：T81024产 地：中国大陆
-
T81021Telimomab aritox；化合物 Telimomab aritoxT101-RTA|||T101-ricin A chain immunotoxin；T101-RTA|||T101-ricin
Telimomab aritox (T101-ricin A chain immunotoxin) is a mouse monoclonal antibody fused to the A chain of ricin protein, functioning as an immunosuppressive agent [1].
价 格：￥电议型 号：T81021产 地：中国大陆
-
T80984Tilogotamab；化合物 TilogotamabGEN-1029|||HexaBody-DR5/DR5|||Hx-DR5-01/05；GEN-1029|||HexaBody-DR5/DR5|||
Tilogotamab (GEN-1029) is an enhanced hexameric mixture of two agonistic antibodies that bind to distinct epitopes on death receptor type 5 (DR5), specifically activating it. This compound is utilized in the research of multiple myeloma (MM) [1].
价 格：￥电议型 号：T80984产 地：中国大陆
-
T80983Tirnovetmab；化合物 TirnovetmabKIND-016；KIND-016
Tirnovetmab (KIND-016), an antibody, is utilized for experimental research purposes.
价 格：￥电议型 号：T80983产 地：中国大陆
-
T80955Trastuzumab duocarmazine；化合物 Trastuzumab duocarmazine(vic)-Trastuzumab duocarmazine；(vic)-Trastuzuma
Trastuzumab duocarmazine ((vic)-Trastuzumab duocarmazine) is an ADC targeting HER2 that undergoes cleavage by histone B within tumor cells, thereby achieving selective targeting of these cells. It exhibits antitumor activity and is applicable in cancer research, particularly concerning uterine and ovarian sarcomas [1].
价 格：￥电议型 号：T80955产 地：中国大陆
-
T80951Trevogrumab；化合物 TrevogrumabREGN-1033；REGN-1033
Trevogrumab (REGN-1033), a monoclonal antibody targeting GDF8 (growth differentiation factor 8, also known as muscle growth inhibitor), is currently under investigation for the treatment of sarcopenia, characterized by wasting atrophy, chronic diseases, and alterations in dietary and nutritional intake [1].
价 格：￥电议型 号：T80951产 地：中国大陆
-
T80945Trinbelimab；化合物 Trinbelimabr-anti-D；r-anti-D
Trinbelimab (r-anti-D), an antibody, is utilized in a range of biochemical studies [1].
价 格：￥电议型 号：T80945产 地：中国大陆
-
T80900Unasnemab；化合物 UnasnemabMT-3921|||rH116A3；MT-3921|||rH116A3
Unasnemab (MT-3921), a humanized IgG1 monoclonal antibody, targets repulsive guidance molecule A (RGMa) to enhance locomotor function and support neuroregeneration, showing potential for spinal cord injury research [1].
价 格：￥电议型 号：T80900产 地：中国大陆
-
T80895Upanovimab；化合物 UpanovimabSCTA01；SCTA01
Upanovimab (SCTA01) is a monoclonal antibody [1].
价 格：￥电议型 号：T80895产 地：中国大陆
-
T80888Urtoxazumab；化合物 UrtoxazumabHuVTm1.1|||TMA-15；HuVTm1.1|||TMA-15
Urtoxazumab (TMA-15) is a humanized monoclonal antibody targeting Shiga toxin 2 (Stx2) [1].
价 格：￥电议型 号：T80888产 地：中国大陆
-
T80877Varisacumab；化合物 VarisacumabR 84 (antibody)|||GNR-011；R 84 (antibody)|||GNR-011
Varisacumab (R 84) is an antibody utilized in diverse biochemical analyses [1].
价 格：￥电议型 号：T80877产 地：中国大陆
-
T80875Vatelizumab；化合物 VatelizumabGBR500；GBR500
Vatelizumab (GBR500), a monoclonal antibody, specifically targets the α2 subunit (CD49b) of very late antigen-2 (VLA-2) and is utilized in multiple sclerosis research [1].
价 格：￥电议型 号：T80875产 地：中国大陆
-
T80863Visugromab；化合物 VisugromabCTL-002；CTL-002
Visugromab, a GDF-15 neutralizing IgG4 monoclonal antibody (mAb), demonstrates potent efficacy in treating PD-1/PD-L1 relapsed/refractory metastatic solid tumors [1].
价 格：￥电议型 号：T80863产 地：中国大陆
-
T80858Vixtimotamab；化合物 VixtimotamabTandAb T564|||AMV-564；TandAb T564|||AMV-564
Vixtimotamab (AMV-564; TandAb T564), a bispecific tetravalent tandem diabody (TandAb), selectively engages human CD33 and CD3 antigens. It is utilized in research on acute myeloid leukemia (AML) [1].
价 格：￥电议型 号：T80858产 地：中国大陆
-
T80762XmAb 5592；化合物 XmAb 5592XmAb 5592
XmAb 5592 is a humanized, Fc-engineered antibody targeting HM1.24 with improved affinity for both FcγRIIIa and FcγRIIa receptors. It enhances lysis of HM1.24-specific multiple myeloma (MM) cells through both antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP) in vitro [1].
价 格：￥电议型 号：T80762产 地：中国大陆
-
T80744Zanolimumab；化合物 ZanolimumabAnti-Human CD4 Recombinant Antibody；Anti-Human CD4 Recombinant Antibody
Zanolimumab (Anti-Human CD4 Recombinant Antibody) is a fully human monoclonal antibody that targets the CD4 molecule and effectively inhibits T-cell receptor (TCR) signal transduction. It is used in the research of rheumatoid arthritis, psoriasis, melanoma, cutaneous, and peripheral T-cell lymphoma [1].
价 格：￥电议型 号：T80744产 地：中国大陆
-
T80726Ziralimumab；化合物 ZiralimumabABX-RB2；ABX-RB2
Ziralimumab (ABX-RB2), an anti-human CD147/BSG monoclonal antibody, is employed for immunosuppression [1].
价 格：￥电议型 号：T80726产 地：中国大陆
-
T80622Trontinemab；化合物 TrontinemabTrontinemab
Trontinemab, a bispecific humanized IgG1-κ antibody, targets the amyloid beta A4 precursor protein (APP) and transferrin receptor p90, CD71 (TFRC). It is utilized in research on Alzheimer´s disease (AD) [1] [2].
价 格：￥电议型 号：T80622产 地：中国大陆
